Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
deals
life sciences
national blog main
national top stories
san francisco blog main
2
×
san francisco top stories
startups
2
×
alphabet
azacitidine
beta-thalassemia
boston
broad institute of harvard and mit
brook byers
charles chu
crispr
crispr cas14
dacogen
decheng capital
decitabine
diagnostic
dna
epigenetics
epizyme
farydak
flagship pioneering
fulcrum therapeutics
google
infectious disease
insulated genomic domains
investing
kaleido biosciences
kleiner perkins
mahesh karande
mammoth biosciences
mayfield
medical devices
new york blog main
What
based
2
×
aims
approach
available
big
bio
biosciences
biotech
called
cas
cheaper
crispr
debuts
develop
developing
diagnostics
drugs
epigenetic
epigenetics
expects
faster
field
flagship’s
mammoth
medicines
morning
new
omega
research
set
startup
step
therapeutics
things
tiny
today
touting
what’s
Language
unset
2
×
Current search:
unset
×
startups
×
based
×
" san francisco blog main "
×
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further